During the past decade, Sai Clinic, Gastrointestinal and Protology Divisions conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sai Clinic, Gastrointestinal and Protology Divisions" are "Colitis, Ulcerative" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Sai Clinic, Gastrointestinal and Protology Divisions" in a lesser frequency.

Most popular intervention types in "Sai Clinic, Gastrointestinal and Protology Divisions" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials), "Guselkumab Dose 2" (1 trials) and "Guselkumab Dose 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sai Clinic, Gastrointestinal and Protology Divisions" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sai Clinic, Gastrointestinal and Protology Divisions". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sai Clinic, Gastrointestinal and Protology Divisions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sai Clinic, Gastrointestinal and Protology Divisions, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".